Search Within

Amanda Kulick

Formats
  1. Journal Article (18)
  2. Meeting Abstract (5)
  3. Research Letter (1)
Groups
  1. GSK Faculty (21)
  2. Sloan Kettering Institute Postdocs (19)
  3. Center for Molecular Imaging and Biotechnology (CMIB) (17)
  4. Sloan Kettering Institute Faculty (16)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (15)
  6. Department of Medicine (15)

More Groups

People
  1. Elisa De Stanchina (22)
  2. Scott Lowe (10)
  3. Yu-jui Ho (8)
  4. Josef Leibold (6)
  5. Alexander Drilon (5)
  6. Janelle Simon (5)

More People

Years
  1. 2024 (3)
  2. 2023 (3)
  3. 2022 (3)
  4. 2021 (4)
  5. 2020 (4)
  6. 2019 (3)

More Years

Publications
  1. Cancer Research (6)
  2. Cancer Discovery (2)
  3. Journal of Nuclear Medicine (2)
  4. Nature Communications (2)
  5. British Journal of Cancer (1)
  6. Cancer Research Communications (1)

More Publications

Publishers
  1. American Association for Cancer Research (9)
  2. Nature Publishing Group (5)
  3. Cell Press (4)
  4. Society of Nuclear Medicine (2)
  5. American Association for the Advancement of Science (1)
  6. Frontiers Media S.A. (1)

More Publishers

Results (24)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • uPAR immuno-PET in pancreatic cancer, aging, and chemotherapy-induced senescence
    Journal Article

    Pratt, E. C.; Mezzadra, R.; Kulick, A.; Kaminsky, S.; Samuels, Z. V.; Loor, A.; de Stanchina, E.; Lowe, S. W.; Lewis, J. S.
    Journal of Nuclear Medicine (2024)

    Fulltext@MSK | Save
  • Zurletrectinib is a next-generation TRK inhibitor with strong intracranial activity against NTRK fusion-positive tumours with on-target resistance to first-generation agents
    Journal Article

    Roa, P.; Foglizzo, V.; Harada, G.; Repetto, M.; Kulick, A.; de Stanchina, E.; de Marchena, M.; Auwardt, S.; Sayed Ahmed, S.; Bremer, N. V.; more...
    British Journal of Cancer (2024)

    Fulltext@MSK | Save
  • Methylation of the chromatin modifier KMT2D by SMYD2 contributes to therapeutic response in hormone-dependent breast cancer
    Journal Article

    Blawski, R.; Vokshi, B. H.; Guo, X.; Kittane, S.; Sallaku, M.; Chen, W.; Gjyzari, M.; Cheung, T.; Zhang, Y.; Simpkins, C.; more...
    Cell Reports (2024)

    Fulltext@MSK | Save
  • A druggable FOXA1-glucocorticoid receptor transcriptional axis drives tumor growth in a subset of non-small cell lung cancer
    Journal Article

    Dorso, M.; Patel, P. T.; Pankov, A.; Boyer, J. A.; Soni, R. K.; Del Priore, I. S.; Hayatt, O.; Kulick, A.; Hagen, C. J.; de Stanchina, E.; more...
    Cancer Research Communications (2023)

    Fulltext@MSK | Save
  • EZH2 inhibition remodels the inflammatory senescence-associated secretory phenotype to potentiate pancreatic cancer immune surveillance
    Journal Article

    Chibaya, L.; Murphy, K. C.; DeMarco, K. D.; Gopalan, S.; Liu, H.; Parikh, C. N.; Lopez-Diaz, Y.; Faulkner, M.; Li, J.; Morris, J. P. 4th; more...
    Nature Cancer (2023)

    Fulltext@MSK | Save
  • The ectonucleotidase CD39 identifies tumor-reactive CD8(+) T cells predictive of immune checkpoint blockade efficacy in human lung cancer
    Journal Article

    Chow, A.; Uddin, F. Z.; Liu, M.; Dobrin, A.; Nabet, B. Y.; Mangarin, L.; Lavin, Y.; Rizvi, H.; Tischfield, S. E.; Quintanal-Villalonga, A.; more...
    Immunity (2023)

    Fulltext@MSK | Save
  • EZH2 inhibition remodels the inflammatory senescence-associated secretory phenotype and promotes immune surveillance in PDAC
    Meeting Abstract

    Chibaya, L.; Murphy, K. C.; Diaz, Y. L.; DeMarco, K. D.; Liu, H.; Gopalan, S.; Faulkner, M.; Li, J.; Morris, J. P. 4th; Ho, Y. J.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Genomic and transcriptomic analysis of a library of small cell lung cancer patient-derived xenografts
    Journal Article

    Caeser, R.; Egger, J. V.; Chavan, S.; Socci, N. D.; Byrne Jones, C.; Kombak, F. E.; Asher, M.; Roehrl, M. H.; Shah, N. S.; Allaj, V.; more...
    Nature Communications (2022)

    Fulltext@MSK | Save
  • Senescence induction dictates response to chemo- and immunotherapy in preclinical models of ovarian cancer
    Journal Article

    Paffenholz, S. V.; Salvagno, C.; Ho, Y. J.; Limjoco, M.; Baslan, T.; Tian, S.; Kulick, A.; de Stanchina, E.; Wilkinson, J. E.; Barriga, F. M.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2022)

    Fulltext@MSK | Save
  • EZH2 blockade overcomes suppression of the proinflammatory senescence-associated secretory phenotype in the pancreas and drives NK cell-mediated pancreatic tumor responses
    Meeting Abstract

    Chibaya, L.; Lopez-Diaz, Y.; Liu, H.; Murphy, K. C.; Morris, J. P. 4th; Ho, Y. J.; Simon, J.; Luan, W.; Kulick, A.; Leang, L.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save